Browse the 369 posters accepted to this year's symposium. Search by author name, by keyword in the title, or narrow to a category. Click any keyword chip on a result to pivot to a related search.
-
DHV 8.5
Reference Values For O2-pulse And Vo2peak For Heart Failure Patients And Indications For Advanced Therapies
-
152 8.23
IN-HOSPITAL OUTCOMES OF ACUTE HEART FAILURE IN BREAST CANCER SURVIVORS WITH CANCER THERAPY-RELATED HEART FAILURE.
-
160 7.57
-
DHV 7.5
Early Detection of Cardiac Allograft Vasculopathy Using AVVIGO+ IVUS: A Retrospective Analysis of Plaque Characteristics
-
157 7.5
CAR-T Therapies Associated with Higher CRS-Linked Cardiotoxicity Signal than BiTE Agents in Multiple Myeloma: Analysis of Adverse Event Report
-
161 7.45
-
139 7.27
Assessing Barriers to Heart Transplantation for Bridge to Decision and Long Term Left Ventricular Assist Device Recipients
-
DHV 7.27
Disparities in Healthcare Burdens Experienced by Heart Transplant Recipients in the First Year After Transplant
-
DHV 7.2
Prospective Evaluation of Early Cardiotoxicity in Patients Undergoing Photon or Proton Radiation Therapy for Locally-Advanced Distal Esophageal Cancer
-
137 7.15
Abstract: Comparison of Reperfusion efficacy in STEMI Patients using ECG ST-Segment Resolution (STR) and Thrombolysis in Myocardial Infarction (TIMI) Flow
-
DHV 7.1
Sex differences in leg microvascular arteriolar function in patients with chronic limb threatening ischemia.
-
DHV 7.05
Longitudinal Optical Coherence Tomography (OCT) Assessment of Abluminus Sirolimus‑Eluting Stent in Diabetic Patients: A 9 Month Paired Analysis
-
138 7.0
Clinical Impact of Heart Failure Readmissions in HeartMate 3 Left Ventricular Assist Device Recipients
-
135 6.67
Associations Between Objectively Measured Movement Behaviors and Diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA)
-
146 6.65
Efficacy of ivabradine in heart rate reduction after cardiac transplantation: Systematic review and meta-analysis
-
148 6.65
Atherosclerotic Cardiovascular Disease and Cardiovascular Risk Factors in Young Women with and without Preterm Delivery: Evidence from the ANCORS YW Study
-
158 6.6
Impact of Mitral Regurgitation Severity on Left Atrial Thrombus Risk in Atrial Fibrillation: A Meta-Analysis
-
134 6.55
SARS-CoV-2 Spike Protein Induces Oxidative Stress and Vascular Remodeling in Rats
-
156 6.45
Flowing Forward: Clinical Outcomes Across Three Generations of LVADs
-
136 6.43
Novel Intracoronary stentriever thrombectomy device as adjunctive reperfusion modality in ST-segment elevation myocardial infarction (STEMI) with large thrombus burden.
-
131 6.33
Incidence and Clinical Outcomes of LVAD-related Infections in a Contemporary Real-World HeartMate 3 Population.
-
155 6.33
Factors associated with successful treatment with temporary right ventricular assist devices for right ventricular failure in recipients of HeartMate 3 left ventricular assist device
-
142 6.2
Optimizing The Use Of Transesophageal Echocardiography In Staphylococcus Aureus Bacteremia
-
DHV 5.93
Automated Characterization of Atherosclerotic Plaque Components in Optical Coherence Tomography (OCT) Using Deep Learning
-
162 5.93
Health-Related Quality of Life in Long-Term LVAD Patients: A Cross-sectional Study
-
153 5.9
Implementation and Quality Improvement of Urine Sodium–Guided Diuretic Dosing in Acute Decompensated Heart Failure: A Resident-Led Educational Model for Heart Failure Management
-
151 5.85
Trends and Disparities in Stroke-Related Mortality among Heart Failure Patients in the United States, 1999─2020
-
141 5.83
-
143 5.8
Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography As A Prognostic Tool For Cardiac Sarcoidosis
-
147 5.77
CARDIAC AND NEUROLOGICAL EFFICACY OF RNA THERAPEUTICS IN TRANSTHYRETIN AMYLOIDOSIS (ATTR): A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
-
133 5.73
Agreement Between Coronary CT Angiography and Intravascular Ultrasound for Target Lesion Plaque Volume Assessment and Its Association With Periprocedural Myocardial Infarction
-
159 5.5
Impact of Opioid Exposure on the Coronary Microvasculature in ANOCA: A Coronary Microvascular Disease Registry Analysis.
-
150 5.43
Trends in Stroke-Related Mortality Among U.S. Patients with Hyperlipidemia, 1999–2020: A CDC WONDER Analysis
-
145 5.4
-
140 5.33
Investigating TRPA1’s Role in Nicotine-induced Pulmonary Vascular Dysfunction
-
154 5.2
Comparison of Pulmonary Embolism Intervention Outcomes by Specialty
-
163 5.15
Clinical outcomes in patients with early right ventricular failure during index admission after HeartMate 3 LVAD implantation
-
144 5.07
Social determinants of health in patients hospitalized with decompensated heart failure
-
132 4.85
Partial Inhibition of Proprotein Convertase Activity by a Stereochemically Defined Phenylpropanoid Glycoside: Implications for Pulmonary Vascular Remodeling
-
149 4.77
Trends and Disparities in Stroke-Related Mortality among Adults with Cardiovascular-Kidney-Metabolic Syndrome: A 25-Year Analysis
-
164 4.55
Fulminant Myocarditis masquerading as STEMI with Bidirectional VT and VFib Arrest: A Case Requiring ECMO and Escalated Support
-
168 4.5
UNSCREWING SIGN : A VISUAL INDICATOR FOR ATRIAL LEADLESS PACEMAKER DISLODGEMENT
-
167 4.43
-
166 4.27
-
169 4.15
Leadless Pacing and Subcutaneous Defibrillation: A Case Series of Combined AVEIR Leadless Pacemaker and S-ICD Implantation
-
165 4.1